In an Editorial published in the British Journal of Pharmacology (BJP), the Editor-in-Chief and Senior Editors have recommended that all future studies published in the journal should formally…
Jonathan Brüün will be leaving his role as CEO of the British Pharmacological Society in January 2020. He will be taking up a new post as Chief Executive of the Royal College of…
Creating your networks You may be aware that we have been reviewing the effectiveness of our Affinity Groups and how we can better support valuable connections and collaboration between our…
Artificial intelligence (AI) is an astonishingly rapidly growing technology and is already ‘changing the game’ in many fields. Together with Big Data, AI has been…
The following article by J. Daniel Lafreniere, Research Associate at Dalhousie University, Canada, has been selected by a panel of judges as the runner up for Pharmacology Matters’ first writing…
Bioprinting is the mechanical deposition of biological materials, controlled by a computerised model. There are various forms of bioprinting technology - from inkjet similar to household dye…
“You can be anywhere you want in the world, meet different people and learn more than a hundred things in a matter of minutes… all you have to do is READ!” – C.M. Okonkwo Dear…
The Life Sciences Post-Translational Modifications and Cell Signalling meeting, which took place 17-18 March 2019 at the East Midlands Conference Centre…
